An understanding of modified release matrix tablets behavior during drug dissolution as the key for prediction of pharmaceutical product performance – case study of multimodal characterization of quetiapine fumarate tablets
- 1 April 2015
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 484 (1-2) , 235-245
Abstract
No abstract availableKeywords
Funding Information
- European Regional Development Fund (UDA-POIS.13.01-023/09-00)
- Bundesministerium für Forschung, Technologie und Raumfahrt (FKZ 03IPT612C)
- Ministerstwo Edukacji i Nauki (NN518 407438)
This publication has 34 references indexed in Scilit:
- Direct Visualization of in Vitro Drug Mobilization from Lescol XL Tablets Using Two-Dimensional 19F and 1H Magnetic Resonance ImagingMolecular Pharmaceutics, 2014
- MRI as a tool for evaluation of oral controlled release dosage formsDrug Discovery Today, 2012
- Gastroretentive drug delivery systems with l-dopa based on carrageenans and hydroxypropylmethylcelluloseInternational Journal of Pharmaceutics, 2011
- Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products: Workshop summary reportClinical Therapeutics, 2010
- Novel Application of MRI Technique Combined with Flow-Through Cell Dissolution Apparatus as Supportive Discriminatory Test for Evaluation of Controlled Release FormulationsAAPS PharmSciTech, 2010
- Clinical Relevance of Dissolution Testing in Quality by DesignThe AAPS Journal, 2008
- QuetiapineCNS Drugs, 2004
- Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rateJournal of Controlled Release, 2001
- Clinical Pharmacokinetics of QuetiapineClinical Pharmacokinetics, 2001
- Observation of swelling process and diffusion front position during swelling in hydroxypropyl methyl cellulose (HPMC) matrices containing a soluble drugJournal of Controlled Release, 1999